VITASPRING BIOMEDICAL CO., LTD.: cashflow_financing
| Value | {"amount": 515, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"} |
|---|---|
| Period | 2025-02-01 – 2025-04-30 |
| Status | current |
| Entity | VITASPRING BIOMEDICAL CO., LTD. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:23:16.246968+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/b4996f3b-b051-449b-834c-ff41a1900216
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001640334-26-001046Retrieved: 2026-08-19T17:23:16.246968+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001697884/cashflow-financing/2025-04-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/b4996f3b-b051-449b-834c-ff41a1900216
History
- no predecessors — first report